Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Novo Nordisk A/S

+ Add to Watchlist


56.4800 USD 0.6400 1.12%

As of 16:15:06 ET on 05/29/2015.

Snapshot for Novo Nordisk A/S (NVO)

Open: 56.3200 Day's Range: 55.7700 - 56.7100 Volume: 2,289,086
Previous Close: 57.1200 52wk Range: 41.7200 - 57.7000 1-Yr Rtn: +35.61%

Stock Chart for NVO

No chart data available.
  • NVO:US 56.4800
  • 1D
  • 1M
  • 1Y
Interactive NVO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NVO

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 29.9228
Relative P/E vs. SPX -
Earnings Per Share (DKK) (ttm) -
Est. EPS (DKK) (12/2015) 12.8310
Est. PEG Ratio 1.9962
Market Cap (M USD) 146,848.00
Shares Outstanding (M) 2,062.56
30 Day Average Volume 1,152,032
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.29%
Cash Dividend (USD) 0.5329
Dividend Ex-Date 03/19/2015
5 Year Dividend Growth 22.18%
Next Earnings Announcement 08/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NVO

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for NVO

Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.

Lars Rebien SorensenPresident/CEOJesper BrandgaardChief Financial Officer
Lars Fruergaard JorgensenExec VP:Corp DevelopmentJakob RiisExec VP: Marketing,Medic Affers&Stakehold ENG
More Company Profile & Key Executives for NVO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil